Discover trends, market shifts, and competitive outlooks for the genital warts industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Genital Warts Market In 2029?

The market for genital warts has seen robust expansion in the past few years. Projections show that it will rise from $1.97 billion in 2024 to $2.08 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. This growth during the historical phase can be related to the attention on patient-oriented care, the rising importance placed on early identification and treatment, growing accessibility of self-targeting therapies, and the increase in clinical trials as well as the recurrence of genital warts.

Expectations are high for the genital warts market, with robust growth anticipated in the coming years. It’s projected that the market will expand to $2.57 billion by 2029, rising at a compound annual growth rate (CAGR) of 5.4%. This substantial growth slated for the forecast period can be linked to several factors including the widespread adoption of telemedicine and digital health platforms for remote consultations and treatment follow-ups, the mounting demand for both affordable and effective treatments for sexually transmitted infections, the rising popularity of loop electrosurgical excision procedures, the intensifying demand for interferon alfa-n3 injections, and the growing accessibility to therapies. In the forecast period, major trends expected to shape the market include technological advancements in diagnostics, a move towards combination therapy strategies, a surge in telehealth use and online consultations, the introduction of new therapeutic targets, and market expansion in emerging economies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Genital Warts Market?

The escalation in cases of sexually transmitted infections (STIs) is propelling the expansion of the genital warts market. STIs predominantly spread via sexual cavity activities such as vaginal, anal, and oral and are triggered by bacteria, viruses or parasites. The escalating incidence of STIs is tied to heightened sexual activity, improper use of protective measures and inadequate access to education or healthcare facilities. Genital warts, a frequent type of STI, are produced by particular strands of the human papillomavirus (HPV), passed on by direct skin contact during sexual engagement. For instance, data from the Joint United Nations Programme on HIV/AIDS, a comprehensive global programme based in Switzerland aimed to prevent HIV, stated that HIV affected around 38.7 million people in 2021. This figure rose to 39.0 million in 2022, with an added 1.3 million new infections recorded in that year. Therefore, the soaring cases of STIs are fuelling the expansion of the genital warts market.

Which Segments in the Genital Warts Offer the Most Growth?

The genital warts market covered in this report is segmented –

1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid

2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments

3) By Gender: Female, Male

4) By End Users: Hospitals, Clinics, Home Care Settings

Subsegmments

1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18374&type=smp

Which Areas Are Leading Regions in the Genital Warts Market Expansion Across the Globe?

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in the Genital Warts Market Over the Coming Years?

Leading businesses within the genital warts market are innovating new treatment methods, such as cutting-edge dermatology medications, to combat the problems encountered by genital warts patients. Dermatology medications relate to modern pharmaceuticals or therapeutic tools crafted explicitly to tackle numerous dermatologic issues like genital warts. For instance, Verrica Pharmaceuticals Inc., a notable dermatology pharmaceutical firm from the US, attained New Chemical Entity (NCE) recognition for their drug prospect YCANTH in March 2023. YCANTH, which is under development for genital warts treatment, has finalised phase 2 trials. The company is now shielded from generic rivalry for at least the subsequent five years, thanks to its FDA NCE status.

View the full report here:

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

What Are the Key Elements That Define the Genital Warts Market?

Genital warts refer to condylomata acuminata, which are sexually transmitted infections (STI) caused by certain strains of the human papillomavirus (HPV). These warts typically appear as small growths or clusters of bumps on or around the genital and anal areas and vary in size and shape, may be raised or flat, and often have a cauliflower-like appearance. Genital warts are usually painless but can cause itching, discomfort, or bleeding during sexual intercourse.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18374

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model